• 8 March 2022

    Celebrating women in Science

    International Women’s day
    Happy International Women’s day to all amazing women all over the world! With an all female team, our gender balance is not perfect, but a great reason to celebrate this day! #iwd2022 #womenatwork. Here.

  • 1 November 2022

    1 November 2022

  • 20 Januari 2021

    Lung on chip models

    The model is suitable for studies on neuro-effector interactions such as neuro-immune interactions and neuron-smooth muscle interactions and for studies into neuroplasticity in asthma.
    This model was developed in collaboration with the University of Groningen and funded by a grant (114021505) from the ZonMW/Proefdiervrij Meer Kennis met Minder Dieren (Animal free – More Knowledge with Fewer Animals) program with co-financing from Boehringer Ingelheim, Lung Foundation Netherlands and Aquilo. See publication

  • 21 Juli 2020

    EVENTS Q3/Q4 2020

    Even though we will not travel for the remainder of 2020, we will have a busy schedule with all these events going digital! This is what our calendar looks like:

    • ChinaBio Partnering Forum – Aug 25-27, 2020 – Digital
    • ERS International Congress – September 7-9 – Digital
    • Biopharm America – September 21–24, 2020 – Digital
    • Bio-Europe – October 26-29, 2020 – Digital

    We’re looking forward to talking to you during one of these meetings!

    21 Juli 2020

  • 6 May 2020


    Following a series of Covid-19 safety measures, aimed at reducing risks to our employees and their families, Aquilo is operating and eager to contribute to therapy development around SARS-CoV-2. Read more.

  • 8 November 2019

    BIO-EUROPE 2019

    Aquilo will be present at the BIO-Europe meeting in Hamburg next week. We have a few spots open for one-to-one partnering, or you can find us at the booth from the Life Cooperative Northern Netherlands at #77! Looking forward to start new collaborations!

    8 November 2019

  • 6 September 2019

    ERS 2019

    Aquilo will be present at the ERS 2019 later this month in Madrid. We would be happy to meet if you’re interested to learn more about our services. See you in Madrid!

  • 25 Juli 2019


    Via the European Fund for Regional Developments (Europees Fonds voor Regionale Ontwikkeling – EFRO), the European Union enables us to further develop the organoid model for efficacy studies on novel drugs for lung fibrosis and COPD. We believe there is a need for better predictive models, including human models, that allow to evaluate the potential for lung repair/regeneration. We will develop novel models using disease stimuli relevant for fibrosis and COPD, including TGF-β, cigarette smoke extract and diesel exhaust particles. Furthermore, we will evaluate the effect of registered and novel drugs on these models. Studies will be performed using mouse and human cells. With this, we hope to generate well-validated pre-clinical models to contribute to drug development for lung fibrosis and COPD.

    25 Juli 2019